Teladoc Health, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -2.2% | -0.6% | -0.3% | 0.0% | -1.7% | +0.4% | -0.9% | +2.5% | -4.4% | -1.1% | – | |
| – | +4.0% | +0.6% | -3.3% | -4.4% | +5.1% | +4.2% | -3.2% | -1.8% | +5.3% | +47.1% | -105.2% | – | |
| – | -1.5% | -3.3% | +0.6% | +1.4% | -2.0% | -4.2% | +2.0% | -0.5% | +1.4% | -27.2% | +92.0% | – | |
| – | -71.1% | +163.0% | +32.1% | +0.6% | -80.9% | +237.9% | +61.6% | -40.2% | +6.0% | -5.2% | -7.4% | – | |
| – | -5.8% | +2.5% | -1.9% | +4.3% | -12.5% | +12.8% | -4.1% | -5.1% | +5.7% | -5.8% | +1.9% | – | |
| – | -6.8% | +7.3% | +140.5% | -61.0% | -1.1% | +10.7% | -10.4% | -0.9% | -2.0% | -22.5% | +76.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.9% | +2.0% | 0.0% | +0.2% | +21.0% | -15.8% | -22.4% | +1.2% | +9.4% | +8.4% | -4.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -23.5% | +44.4% | -79.9% | -69.5% | -7,770.2% | – | – | – | – | -66.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +231.4% | -123.1% | – | -19.4% | -12.0% | -176.1% | – | -1,415.2% | – | -24.3% | -421.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.